XML 30 R29.htm IDEA: XBRL DOCUMENT
v2.4.0.8

SEGMENT AND GEOGRAPHIC INFORMATION (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2014
Segment Reporting [Abstract] |
Total Revenue By Major Geographic Area | Net sales and profit by reportable segment for the three and nine months ended September 30, 2014 and 2013 are as follows:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2014 |  | 2013 |  | 2014 |  | 2013
|  | (In thousands)
|  |  |  | (As adjusted)* |  |  |  | (As adjusted)*
Segment Net Sales |  |  |  |  |  |  |  |
U.S. Neurosurgery |  | $ | 62,323 |  |  | $ | 45,114 |  |  | $ | 177,265 |  |  | $ | 125,877 |
U.S. Instruments |  | 39,853 |  |  | 43,004 |  |  | 116,078 |  |  | 121,900 |
U.S. Extremities |  | 36,746 |  |  | 31,831 |  |  | 103,083 |  |  | 93,802 |
U.S. Spine and Other |  | 42,015 |  |  | 47,408 |  |  | 128,168 |  |  | 134,889 |
International |  | 48,782 |  |  | 45,889 |  |  | 151,535 |  |  | 138,977 |
Total revenues |  | $ | 229,719 |  |  | $ | 213,246 |  |  | $ | 676,129 |  |  | $ | 615,445 |
Segment Profit |  |  |  |  |  |  |  |
U.S. Neurosurgery |  | $ | 35,889 |  |  | $ | 23,080 |  |  | $ | 94,247 |  |  | $ | 59,770 |
U.S. Instruments |  | 12,416 |  |  | 13,713 |  |  | 34,728 |  |  | 35,963 |
U.S. Extremities |  | 14,983 |  |  | 13,117 |  |  | 40,907 |  |  | 34,613 |
U.S. Spine and Other |  | 13,108 |  |  | (31,043 | ) |  | 39,801 |  |  | (4,844 | )
International |  | 15,170 |  |  | 14,693 |  |  | 49,549 |  |  | 41,697 |
Segment profit |  | 91,566 |  |  | 33,560 |  |  | 259,232 |  |  | 167,199 |
Amortization |  | (2,995 | ) |  | (3,036) |  |  | (9,013) |  |  | (9,660) |
Corporate and other |  | (70,844 | ) |  | (61,665 | ) |  | (211,362 | ) |  | (185,314 | )
Operating income (loss) |  | $ | 17,727 |  |  | $ | (31,141 | ) |  | $ | 38,857 |  |  | $ | (27,775 | )
* See Note 1 of these condensed consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax. Certain 2013 segment revenues and the related impact on segment profit above have been reclassified in order to conform with the current year's presentation. Revenue by major product category consisted of the following:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2014 |  | 2013 |  | 2014 |  | 2013
| (In thousands)
Orthopedics | $ | 91,650 |  |  | $ | 92,125 |  |  | $ | 271,958 |  |  | $ | 271,862 |
Neurosurgery | 92,089 |  |  | 72,639 |  |  | 269,717 |  |  | 204,283 |
Instruments | 45,980 |  |  | 48,482 |  |  | 134,454 |  |  | 139,300 |
Total Revenues | $ | 229,719 |  |  | $ | 213,246 |  |  | $ | 676,129 |  |  | $ | 615,445 |
The Company attributes revenues to geographic areas based on the location of the customer. There are certain revenues managed by the various U.S. segments that are generated from non-U.S. customers and therefore are included in Europe and the Rest of World revenues below. Total revenue by major geographic area consisted of the following:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2014 |  | 2013 |  | 2014 |  | 2013
| (In thousands)
United States | $ | 180,101 |  |  | $ | 166,555 |  |  | $ | 522,288 |  |  | $ | 473,740 |
Europe | 23,850 |  |  | 21,543 |  |  | 75,026 |  |  | 68,936 |
Rest of World | 25,768 |  |  | 25,148 |  |  | 78,815 |  |  | 72,769 |
Total Revenues | $ | 229,719 |  |  | $ | 213,246 |  |  | $ | 676,129 |  |  | $ | 615,445 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8721-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration